(MD4X) Lyxor German Mid-Cap MDAX - Ratings and Ratios
German Stocks, Mid-Cap Stocks, Small-Cap Stocks
Description: MD4X Lyxor German Mid-Cap MDAX
The Lyxor German Mid-Cap MDAX UCITS D-EUR (XETRA:MD4X) is an ETF that tracks the MSCI Germany Small Cap NR EUR index, providing exposure to German small-cap equities. As a Germany Small/Mid-Cap Equity ETF, it is designed to capture the performance of mid-cap companies in Germany.
To evaluate the ETFs performance, we can look at key metrics such as tracking error, liquidity, and expense ratio. Although the exact tracking error and expense ratio are not provided, we can infer that the ETF is relatively liquid given its listing on XETRA and AUM of 213.08M EUR. A more detailed analysis would require examining the ETFs holdings, sector allocation, and market capitalization distribution to understand its risk profile and potential for returns.
From a technical analysis perspective, the ETFs price action indicates a bullish trend, with the short-term and long-term moving averages (SMA20 and SMA50) converging, suggesting a potential breakout. The ETFs price is currently near its 52-week high, indicating strong performance. Key performance indicators (KPIs) such as the Relative Strength Index (RSI) and Bollinger Bands could provide further insights into the ETFs momentum and volatility.
To make informed investment decisions, its essential to consider the ETFs underlying index, the MSCI Germany Small Cap NR EUR, and its constituent stocks. Analyzing the indexs historical performance, sector allocation, and market capitalization distribution can help investors understand the ETFs potential risks and rewards. Additionally, comparing the ETFs performance to its benchmark and peers can help evaluate its effectiveness in capturing the desired market exposure.
Additional Sources for MD4X ETF
MD4X ETF Overview
Market Cap in USD | 249m |
Category | Germany Small/Mid-Cap Equity |
TER | 0.20% |
IPO / Inception | 2014-05-15 |
MD4X ETF Ratings
Growth Rating | 5.26 |
Fundamental | - |
Dividend Rating | 42.1 |
Rel. Strength | -6.51 |
Analysts | - |
Fair Price Momentum | 150.66 EUR |
Fair Price DCF | - |
MD4X Dividends
Dividend Yield 12m | 1.97% |
Yield on Cost 5y | 2.09% |
Annual Growth 5y | 11.24% |
Payout Consistency | 87.5% |
Payout Ratio | % |
MD4X Growth Ratios
Growth Correlation 3m | 69.1% |
Growth Correlation 12m | 81.8% |
Growth Correlation 5y | -51.8% |
CAGR 5y | 2.56% |
CAGR/Max DD 5y | 0.06 |
Sharpe Ratio 12m | 1.24 |
Alpha | 12.18 |
Beta | 0.586 |
Volatility | 15.36% |
Current Volume | 3.7k |
Average Volume 20d | 3.1k |
Stop Loss | 145.6 (-3%) |
As of July 16, 2025, the stock is trading at EUR 150.12 with a total of 3,728 shares traded.
Over the past week, the price has changed by +1.43%, over one month by +3.95%, over three months by +16.95% and over the past year by +20.81%.
Neither. Based on ValueRay´s Analyses, Lyxor German Mid-Cap MDAX is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 5.26 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of MD4X is around 150.66 EUR . This means that MD4X is currently overvalued and has a potential downside of 0.36%.
Lyxor German Mid-Cap MDAX has no consensus analysts rating.
According to our own proprietary Forecast Model, MD4X Lyxor German Mid-Cap MDAX will be worth about 169 in July 2026. The stock is currently trading at 150.12. This means that the stock has a potential upside of +12.54%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 169 | 12.5% |